ASIA unversity:Item 310904400/99866
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 94286/110023 (86%)
造访人次 : 21655008      在线人数 : 416
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/99866


    题名: Drug Repositioning for Non-Small Cell Lung Cancer by Using Machine Learning Algorithms and Topological Graph Theory
    作者: Huang), 黃建宏(Chien-Hung;Chang), Peter Mu-Hsi(Peter Mu-Hsin;Hsu), Chia-Wei Hsu(Chia-Wei;Huang), Chi-Ying Hua(Chi-Ying;吳家樂(Ng, Ka-Lok)*
    贡献者: 生物資訊與醫學工程學系
    日期: 2016-01
    上传时间: 2016-08-08 03:16:13 (UTC+0)
    摘要: Background

    Non-small cell lung cancer (NSCLC) is one of the leading causes of death globally, and research into NSCLC has been accumulating steadily over several years. Drug repositioning is the current trend in the pharmaceutical industry for identifying potential new uses for existing drugs and accelerating the development process of drugs, as well as reducing side effects.

    Results

    This work integrates two approaches - machine learning algorithms and topological parameter-based classification - to develop a novel pipeline of drug repositioning to analyze four lung cancer microarray datasets, enriched biological processes, potential therapeutic drugs and targeted genes for NSCLC treatments. A total of 7 (8) and 11 (12) promising drugs (targeted genes) were discovered for treating early- and late-stage NSCLC, respectively. The effectiveness of these drugs is supported by the literature, experimentally determined in-vitro IC50 and clinical trials. This work provides better drug prediction accuracy than competitive research according to IC50 measurements.

    Conclusions

    With the novel pipeline of drug repositioning, the discovery of enriched pathways and potential drugs related to NSCLC can provide insight into the key regulators of tumorigenesis and the treatment of NSCLC. Based on the verified effectiveness of the targeted drugs predicted by this pipeline, we suggest that our drug-finding pipeline is effective for repositioning drugs.

    Keywords: Non-small cell lung cancer, Drug repositioning, Microarray data analysis, Machine learning algorithm, Topological parameters, Protein-protein interactions, Enrichment analysis, Connectivity Map
    關聯: BMC BIOINFORMATICS
    显示于类别:[生物資訊與醫學工程學系 ] 期刊論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML323检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈